Steven Cook Sells 15,235 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 15,235 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $25.03, for a total transaction of $381,332.05. Following the sale, the chief financial officer directly owned 187,209 shares of the company’s stock, valued at approximately $4,685,841.27. The trade was a 7.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Omada Health Trading Up 2.2%

NASDAQ:OMDA opened at $24.37 on Friday. The stock has a market capitalization of $1.49 billion, a P/E ratio of 487.40 and a beta of 1.73. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The firm has a 50 day moving average of $20.87 and a 200-day moving average of $16.43.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.67% and a net margin of 1.39%.The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. As a group, analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Omada Health

Several hedge funds have recently added to or reduced their stakes in OMDA. Perceptive Advisors LLC acquired a new stake in Omada Health in the second quarter worth about $44,402,000. Millennium Management LLC lifted its position in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after purchasing an additional 2,096,705 shares during the period. BlackRock Inc. acquired a new position in Omada Health during the 2nd quarter valued at about $48,775,000. Loomis Sayles & Co. L P boosted its stake in shares of Omada Health by 23.0% in the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock valued at $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Finally, Jefferies Financial Group Inc. bought a new position in shares of Omada Health in the 4th quarter valued at about $16,948,000.

More Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Q2 results exceeded expectations. Omada reported adjusted earnings of $0.08 per share, compared with analysts’ expectation of a $0.02 loss, while revenue of approximately $87.8 million topped the $80.9 million consensus estimate. The results suggest growth in its digital chronic-care platform is increasingly converting into profitability. Omada Health Q2 earnings analysis
• Positive Sentiment: Several analysts raised their targets. Robert W. Baird lifted its price target from $15 to $25, while maintaining a neutral rating. Other recent targets include $27 from Citizens JMP and $35 from BTIG. The broader analyst consensus remains “Moderate Buy,” with an average target around $25.67–$25.75.
• Positive Sentiment: Institutional ownership increased. Perceptive Advisors and BlackRock reportedly initiated positions, Millennium Management expanded its stake, and Versant Capital Management increased its holdings by more than 300%. These moves may reinforce investor confidence in Omada’s growth outlook.
• Neutral Sentiment: Baird’s neutral stance highlights limited near-term upside. Its $25 target is only modestly above the recent trading level, suggesting the earnings beat and growth prospects may already be substantially reflected in the stock price.
• Negative Sentiment: Multiple senior executives sold shares. CEO Sean Duffy sold 8,628 shares, CFO Steven Cook sold 16,842 shares across two transactions, President Wei-Li Shao sold 8,866 shares, and Chief Accounting Officer Craig Gracey sold 1,042 shares. Although these sales may reflect personal liquidity or compensation planning, concentrated selling near $25 can weigh on sentiment. Omada Health insider trading report
• Negative Sentiment: Valuation risk remains elevated. Omada’s market capitalization is approximately $1.5 billion, while its reported price-to-earnings ratio is above 475. With the shares close to their 52-week high, any slowdown in revenue growth or profitability could prompt profit-taking.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Wells Fargo & Company lifted their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Weiss Ratings raised shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research note on Tuesday. Morgan Stanley reiterated an “overweight” rating and set a $30.00 target price on shares of Omada Health in a research report on Monday, June 22nd. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $25.75.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.